HuGE Literature Finder
|
||
Records 1-5
|
Targeted next-generation sequencing detects a high frequency of potentially actionable mutations in metastatic breast cancers.
Experimental and molecular pathology 2016 Apr 100 (3): 421-425. Muller Kristen E, Marotti Jonathan D, de Abreu Francine B, Peterson Jason D, Miller Todd W, Chamberlin Mary D, Tsongalis Gregory J, Tafe Laura |
|
Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Aug 17 (8): 2101-8. Wang Xianshu, Goode Ellen L, Fredericksen Zachary S, Vierkant Robert A, Pankratz V Shane, Liu-Mares Wen, Rider David N, Vachon Celine M, Cerhan James R, Olson Janet E, Couch Fergus |
|
The I1307K APC mutation in a high-risk clinic setting: a follow-up study.
Clinical genetics 2005 Apr 67 (4): 352-5. Regev M, Barzilai S-Eisenberg, Figer A, Zidan J, Fidder H H, Friedman |
|
The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.
Cancer 2001 Jul 92 (2): 440-5. Bahar AY, Taylor PJ, Andrews L, Proos A, Burnett L, Tucker K, Friedlander M, Buckley MF |
|
Association of APC and MCC polymorphisms with increased breast cancer risk in an Indian population.
The International journal of biological markers 0 26 (1): 43-9. Mukherjee Nupur, Bhattacharya Nilanjana, Sinha Satyabrata, Alam Neyaz, Chakravarti Runu, Roychoudhury Susanta, Panda Chinmay Kum |
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: